HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rusckowski, M. Articles by Hnatowich, D. J. Search for Related Content PubMed PubMed Citation Articles by Rusckowski, M. Articles by Hnatowich, D. J.

Localization of Infection Using Streptavidin and Biotin: An Alternative to Nonspecific Polyclonal Immunoglobulin

Department of Nuclear Medicine, University of Massachusetts Medical Center, Worcester, Massachusetts

Correspondence: For reprints contact: Mary Rusckowski, PhD, Department of Nuclear Medicine, University of Massachusetts Medical Center, 55 Lake Avenue North, Worcester, MA 01655.

ABSTRACT

Since favorable images of infection are obtained with radio labeled nonspecific IgG, streptavidin has been considered as an alternative protein in this investigation. The advantage of streptavidin is that once localized it may be targeted with radiolabeled blotin. Studies were conducted in a mouse model with an Escherichia coli infection in one thigh. Indium-111-labeled streptavidin showed equivalent localization to the infection as that obtained with ¹¹¹In-labeled polyclonal non-specific IgG, however blood levels with streptavidin were lower at all time points; consequently, target-to-blood ratios were improved. Pretargeting with unlabeled streptavidin followed 3 hr later with ¹¹¹In-labeled biotin showed equivalent localization in the target and reduced activity in all organs sampled. As such, infected thigh-to-normal thigh ratios were improved 3-fold for pretargeting versus either labeled IgG or streptavidin. Improvements in infected thigh-to-liver and blood ratios were greater than 8-fold. Only in the case of kidneys was the ratio unimproved. In conclusion, we have shown that by pre-administration of unlabeled streptavidin followed by labeled biotin, infectious lesions in a mouse model may be imaged earlier with lower background levels relative to the administration of labeled nonspecific IgG.

This article has been cited by other articles:

				G. Liu, S. Dou, G. Mardirossian, J. He, S. Zhang, X. Liu, M. Rusckowski, and D. J. Hnatowich Successful Radiotherapy of Tumor in Pretargeted Mice by 188Re-Radiolabeled Phosphorodiamidate Morpholino Oligomer, a Synthetic DNA Analogue. Clin. Cancer Res., August 15, 2006; 12(16): 4958 - 4964. [Abstract] [Full Text] [PDF]

				M. Rusckowski, S. Gupta, G. Liu, S. Dou, and D. J Hnatowich Investigations of a 99mTc-Labeled Bacteriophage as a Potential Infection-Specific Imaging Agent J. Nucl. Med., July 1, 2004; 45(7): 1201 - 1208. [Abstract] [Full Text] [PDF]

				C.-H. Chang, R. M. Sharkey, E. A. Rossi, H. Karacay, W. McBride, H. J. Hansen, J.-F. Chatal, J. Barbet, and D. M. Goldenberg Molecular Advances in Pretargeting Radioimunotherapy with Bispecific Antibodies Mol. Cancer Ther., May 1, 2002; 1(7): 553 - 563. [Abstract] [Full Text] [PDF]

				G. Liu, K. Mang'era, N. Liu, S. Gupta, M. Rusckowski, and D. J. Hnatowich Tumor Pretargeting in Mice Using 99mTc-Labeled Morpholino, a DNA Analog J. Nucl. Med., March 1, 2002; 43(3): 384 - 391. [Abstract] [Full Text] [PDF]

				O. C. Boerman, J. van Eerd, W. J.G. Oyen, and F. H.M. Corstens A 3-Step Pretargeting Strategy to Image Infection J. Nucl. Med., September 1, 2001; 42(9): 1405 - 1411. [Abstract] [Full Text] [PDF]